1.0TechGALA Japan 2026: BEYONDhttps://techgala.jpIB-TechGALAhttps://techgala.jp/author/ib-techgala/rich600338<blockquote class="wp-embedded-content" data-secret="7vPRHEwDcG"><a href="https://techgala.jp/en/p0005/">p0005</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://techgala.jp/en/p0005/embed/#?secret=7vPRHEwDcG" width="600" height="338" title="“p0005” — TechGALA Japan 2026: BEYOND" data-secret="7vPRHEwDcG" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://techgala.jp/wp-includes/js/wp-embed.min.js </script> iBody Inc. Tomoya Nakanishi Transforming antibody discovery, Transforming medicine iBody accelerates the development of next-generation therapeutics and diagnostics by delivering high-performance monoclonal antibodies that meet challenging research and development needs.Our proprietary antibody discovery platform enables rapid identification of antibodies against difficult targets, helping customers reduce development time, overcome technical barriers, and improve R&D success.With patented […]https://techgala.jp/wp-content/uploads/2026/10/iBody.jpg295157